Platelet reactivity evaluated with the VASP assay following ticagrelor loading dose in acute coronary syndrome patients undergoing percutaneous coronary intervention.

Authors:

Marc Laine Richard Toesca Julie Berbis Corinne Frere Pierre Barnay Michel Pansieri Jean-Pascal Peyre Pierre Michelet Jacques Bessereau Elise Camilleri Olfa Helaf Marjorie Camaleonte Franck Paganelli Françoise Dignat-George Laurent Bonello

Thromb Res 2013 Jul 30;132(1):e15-8. Epub 2013 May 30.

Département de cardiologie, Hôpital universitaire nord, Aix-Marseille Univ., Marseille, France.

Background: The level of platelet reactivity (PR) inhibition obtained after P2Y12-ADP receptor antagonist loading dose (LD) is associated with the ischemic and bleeding risk following percutaneous coronary intervention (PCI) in acute coronary syndromes (ACS).

Objective: We aimed to evaluate the level of PR inhibition achieved by a 180 mg LD of ticagrelor and the rate of high on-treatment platelet reactivity (HTPR) in ACS patients undergoing PCI.

Methods: We performed a multicentre prospective observational study enrolling ACS patients undergoing PCI. Patients were included if they were admitted for ST-elevation myocardial infarction or non ST-elevation ACS. To assess PR, a VASP index was measured at least 6 and within 24 hours following a 180 mg LD of ticagrelor. HTPR was defined as a VASP index ≥50%.

Results: One hundred and fifteen patients were included: 31.3% of STEMI, 49.6% of NSTEMI and 19.1% of unstable angina. Following ticagrelor LD the mean VASP index was 17±14%. However the response to ticagrelor was not uniform with a small inter-individual variability: inter quartile range: 7.6-22.8% and a rate of HTPR of 3.5%. A high number of patients, 65.6%, had a VASP index <16%. None of the baseline characteristics of the study population was associated with PR. In addition, PR was similar in STEMI, NSTEMI and unstable angina (p=0.9).

Conclusion: In ACS patients the level of PR inhibition achieved by a 180 mg loading dose of ticagrelor is not uniform and the rate of HTPR is 3.5%. A high proportion of patients exhibited a VASP index <16%.

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.thromres.2013.04.030	DOI Listing

July 2013

Publication Analysis

Top Keywords

coronary intervention

patients included

percutaneous coronary

admitted st-elevation

myocardial infarction

st-elevation myocardial

Keyword Occurance

Similar Publications

Safety of Ticagrelor in Moderate and Severe Acute Ischemic Stroke: A Single-Center Retrospective Review.

Authors:

Stephen W English David R Landzberg Nirav R Bhatt Michael R Frankel Digvijaya Navalkele

J Stroke Cerebrovasc Dis 2021 Apr 2;30(6):105767. Epub 2021 Apr 2.

Marcus Stroke and Neuroscience Center, Grady Memorial Hospital, and the Department of Neurology, Emory University/Grady Memorial Hospital, Atlanta, GA, USA. Electronic address:

Objectives: Ticagrelor may be superior to aspirin after minor ischemic stroke or TIA, particularly in patients with symptomatic atherosclerotic disease. However, there may be an increased risk of intracerebral hemorrhage in patients with moderate to severe ischemic stroke, and ticagrelor has not been studied in this patient population. Therefore, we sought to evaluate the safety of ticagrelor after moderate or severe ischemic stroke. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Platelet antibodies identification: comparison between two laboratory tests.

Authors:

Valeria de Freitas Dutra Thiago Henrique Costa Leandro Dinalli Santos Marilia Fernandes Mascarenhas Sirianni Maria Giselda Aravechia José Mauro Kutner Carolina Bonet Bub

Hematol Transfus Cell Ther 2021 Mar 6. Epub 2021 Mar 6.

Hospital Israelita Albert Einstein, São Paulo, SP, Brazil.

Introduction: Platelet antibody identification is indispensable for diagnosing the human platelet antigen (HPA) or human leukocyte antigen (HLA) immunization, mostly because it can restrict the compatibility and results of transfusions. Correct detection of these antibodies is of utmost importance for the diagnosis and treatment.

Method: We present 16 platelet alloimmunization results, comparing two tests with different technologies: the MAIPA (monoclonal antibody immobilization of platelet antigens), as a reference technique, and a bead-based assay, the Pak-Lx. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy.

Authors:

Ping-Yen Liu Cheng-Huang Su Feng-Yu Kuo Wen-Lieng Lee Yi-Chih Wang Wei-Shiang Lin Pao-Hsien Chu Tse-Min Lu Ping-Han Lo Cheng-Han Lee Wei-Ren Lan Chien-Lung Huang Shuji Tsukiyama Wei-Chen Yang Li-Chung Cheng Virginia Rafael Christian Nikolajsen Wei-Hsian Yin

Cardiovasc Interv Ther 2021 Apr 4. Epub 2021 Apr 4.

Faculty of Medicine, School of Medicine, National Yang Ming University, Taipei, Taiwan.

The recommended maintenance dose of prasugrel for East Asian populations (i.e., Japanese and Taiwanese) is 3. Read More

View Article and Full-Text PDF

April 2021

Similar Publications

Examination of the Efficacy and Cross-Reactivity of a Novel Polyclonal Antibody Targeting the Disintegrin Domain in SVMPs to Neutralize Snake Venom.

Authors:

Shelby S Szteiter Ilse N Diego Jonathan Ortegon Eliana M Salinas Abcde Cirilo Armando Reyes Oscar Sanchez Montamas Suntravat Emelyn Salazar Elda E Sánchez Jacob A Galan

Toxins (Basel) 2021 Mar 31;13(4). Epub 2021 Mar 31.

National Natural Toxins Research Center (NNTRC), Texas A&M University-Kingsville, MSC 224, 975 West Avenue B, Kingsville, TX 78363, USA.

Snake envenomation can result in hemorrhage, local necrosis, swelling, and if not treated properly can lead to adverse systemic effects such as coagulopathy, nephrotoxicity, neurotoxicity, and cardiotoxicity, which can result in death. As such, snake venom metalloproteinases (SVMPs) and disintegrins are two toxic components that contribute to hemorrhage and interfere with the hemostatic system. Administration of a commercial antivenom is the common antidote to treat snake envenomation, but the high-cost, lack of efficacy, side effects, and limited availability, necessitates the development of new strategies and approaches for therapeutic treatments. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Protein Disulphide Isomerase and NADPH Oxidase 1 Cooperate to Control Platelet Function and Are Associated with Cardiometabolic Disease Risk Factors.

Authors:

Renato Simões Gaspar Tanya Sage Gemma Little Neline Kriek Giordano Pula Jonathan M Gibbins

Antioxidants (Basel) 2021 Mar 23;10(3). Epub 2021 Mar 23.

Institute for Cardiovascular and Metabolic Research, School of Biological Sciences, University of Reading, Reading RG6 6AH, UK.

Background: Protein disulphide isomerase (PDI) and NADPH oxidase 1 (Nox-1) regulate platelet function and reactive oxygen species (ROS) generation, suggesting potentially interdependent roles. Increased platelet reactivity and ROS production have been correlated with cardiometabolic disease risk factors.

Objectives: To establish whether PDI and Nox-1 cooperate to control platelet function. Read More

View Article and Full-Text PDF

March 2021

Similar Publications

Search Our Scientific Publications & Authors